Tags: Arthritis | Chronic Pain | ilaris | arthritis | novartis | children | joint

New Treatment for Childhood Arthritis

Friday, 10 May 2013 11:47 AM

 

Novartis said the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis.

Ilaris inhibits interleukin-1 beta, excessive production of which plays a prominent role in certain inflammatory diseases, the company said.

The drug is the only approved treatment specifically for the condition that can be given as a monthly subcutaneous injection, Novartis said.

Ilaris is also approved in the European Union for the treatment of refractory gouty arthritis, Novartis said.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Drug Fights Binge Eating Disorder

Saturday, 31 Jan 2015 10:04 AM

The U.S. Food and Drug Administration on Friday approved Shire's stimulant Vyvanse to treat binge-eating disorder, the f . . .

Drug for Low Thyroid Condition

Tuesday, 27 Jan 2015 12:41 PM

A new drug has been approved to raise calcium levels in patients with low thyroid conditions. The U.S. Food and Drug Adm . . .

Combo Blood Pressure Medication

Tuesday, 27 Jan 2015 12:34 PM

A new combination pill to treat people with high blood pressure has won approval from the U.S. Food and Drug Administrat . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved